IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Propel Bio Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 18 holdings | $86.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Plains GP Holdings LP-Cl(PAGPEUR)COMM72651A207$27.2M1,272,36031.6%
Madrigal Pharmaceuticals(MDGL)COMM558868105$9.9M30,03211.6%
Akero Therapeutics Inc(AKRO)COMM00973Y108$9.3M228,88410.8%
Phathom Pharmaceuticals I(PHAT)COMM71722W107$7.1M1,134,9278.3%
Achieve Life Sciences Inc(ACHV)COMM004468500$6.5M2,453,0927.6%
Applied Therapeutics Inc(APLT)COMM03828A101$5.5M11,285,4206.4%
Avidity Biosciences Inc(RNA)COMM05370A108$5.3M178,5006.1%
Abeona Therapeutics Inc(ABEO)COMM00289Y206$3.0M624,0223.5%
Tscan Therapeutics Inc(TCRX)COMM89854M101$2.9M2,087,1393.3%
Delcath Systems Inc(DCTH)COMM24661P807$2.3M177,6002.6%
Syndax Pharmaceuticals in(SNDX)COMM87164F105$2.3M183,2592.6%
Zevra Therapeutics Inc(ZVRA)COMM488445206$1.3M179,8741.6%
Milestone Pharmaceuticals(MIST)COMM59935V107$1.2M1,451,5571.3%
Maat Pharma SacaCOMMF5888J116$1.0M166,4231.2%
Compass Therapeutics Inc(CMPX)COMM20454B104$433.8K228,3170.5%
Athira Pharma IncCOMM04746L104$425.3K1,492,7920.5%
Eiger Biopharmaceuticals(72C)COMM28249U204$423.0K146,3810.5%
Chinook Therapeutics(KDNY)COMM169CVR016$38.5K79,3570.0%